Danaher is trading up 4.07% at $233.37 on October 21 after Q3 adjusted EPS of $2.11 beat expectations of $1.92. - Revenue rose 8.5% to $6.6 billion. - Management raised 2026 adjusted EPS guidance to $8.57–$8.62, from $8.45–$8.60. - Healthcare was also rising, though the earnings release is the more direct explanation for the move. No volume information was provided.